NetScientific, a UK-based commercialisation firm chaired by former GlaxoSmithKline chairman Richard Sykes, has unveiled plans to raise £30m ($47m) in an initial public offering on London’s AIM market, valuing the company at £57.5m.

The company, which maintains a presence in Cambridge and New York in addition to its Amersham HQ, develops and commercialises research and technology emanating from a number of UK universities, hospitals, and research institutes, as well as Drexel University in the US.

The IPO will be used…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?